Most hormone therapy clinics start with a prescription. Castle Rock Hormone Health starts with a question: What do the numbers actually say? The Colorado-founded hormone replacement and optimization franchise has built its entire clinical model around one principle: that treating hormonal imbalance without consistent data is guesswork, and guesswork does not restore health. With more than 10,000 patients served across five states, the company's founding physician, Dr. Lee Moorer, has spent years turning that principle into a repeatable, science-grounded protocol that now underpins a fast-growing franchise network in preventive medicine.
Beyond the Reference Range
Standard medicine has a problem with reference ranges. When a lab result falls within the population-based "normal" range, most clinics move on. Castle Rock Hormone Health does not.
Dr. Moorer's protocols are built around what the company calls optimal hormone ranges—individualized targets calibrated to each patient's physiology, symptoms, lifestyle, and goals rather than to population averages. A level within the broad statistical range for a 55-year-old may still be too low for that patient to feel well, function clearly, or maintain healthy body composition. The population range indicates what is statistically common. The optimal range tells them what that particular patient needs to thrive.
The hormone panel CRHH uses goes considerably further than a basic testosterone or estrogen check. According to the company's published clinical materials, the panel measures total and free testosterone, estradiol, sex hormone-binding globulin, LH, and FSH, a multi-biomarker picture that allows providers to assess how hormones interact rather than reading each value in isolation. That interaction matters. A testosterone level that reads adequately on paper can still cause low-testosterone symptoms if sex hormone-binding globulin is elevated, because the protein binds the hormone, reducing its availability to the body.
"Hormone therapy should be a precise, data-driven medical process," said Dr. Lee Moorer, co-founder and medical director of Castle Rock Hormone Health.
How Monitoring Keeps the Model Honest
Getting the initial diagnosis right is one challenge. Keeping the protocol accurate over time is another. Castle Rock Hormone Health addresses that through a minimum 90-day monitoring cycle, including at least 4 lab reviews per year for every enrolled patient.
That cadence is not incidental. Hormones shift with age, stress, weight change, and lifestyle. A protocol calibrated in January may need adjustment by April. Without regular data, a provider is making treatment decisions based on outdated information. With it, they can see how a patient is responding, identify early drift from optimal ranges, and adjust before symptoms return. According to the company, treatment is managed to evolve with the patient rather than relying on a single snapshot taken at the beginning of care.
Lab results are typically returned within 24 hours, and a follow-up provider appointment is available within 24 to 48 hours of those results. The same provider sees the patient at every visit, a deliberate structural choice the company says supports continuity and relationship-driven medicine rather than the rotating-provider experience common in high-volume clinical systems. After-hours support is also available. The combination produces a patient relationship with a cadence that feels less like episodic medical visits and more like an ongoing, monitored health partnership.
From Symptoms to Signal
Hormone care often lives in a gray zone. Fatigue, brain fog, weight gain, low libido, and poor recovery can point in many directions, which is one reason the category has drawn both interest and skepticism. Castle Rock Hormone Health frames its model as a way to reduce that ambiguity. Rather than treating symptoms alone as proof, the clinic says it uses structured clinical review to determine whether the data support a hormonal explanation and whether a change in care is actually warranted.
That distinction matters more than it may seem. Plenty of clinics can order labs. Fewer can explain how those results are interpreted, how one biomarker changes the meaning of another, or why a provider would choose to hold a protocol steady instead of reacting to every complaint. Protocol science, at its best, is not about chasing numbers. It is about building a consistent method for separating noise from a meaningful pattern.
Viewed that way, the model's strength lies in its clinical discipline. A system gains credibility when it gives providers a clear basis for judgment, especially in a field where symptoms can be vague and patient expectations can run high. Castle Rock Hormone Health presents its method as one built to make those judgments more deliberate, more traceable, and less dependent on instinct alone.
Dr. Moorer states, "At Castle Rock Hormone Health, we no longer accept the idea of 'normal' when it comes to hormone laboratory values. If one looks at pre-1980 data, a 19–20-year-old male had a normal testosterone level of approximately 900 ng/dL. If one looks at normative values for a 19–20-year-old male in 2026, that range has changed dramatically from 900 ng/dl to approximately 150 to 700 ng/dL. If one accepts the probability that a 19-year-old male has had a normal testosterone level of approximately 900 ng/dl for over 100,000 years, and now, in the 2020's, with obesity, diabetes, sedentary living, and a toxic environment running rampant around the globe, why are medical providers still looking at testosterone levels in the 300 and 400 and saying to themselves, 'oh, look, this guy's testosterone is normal!' This is not normal! This is just normal for a group of people who are obese, chronically ill, and living in a toxic soup of toxins. It is out of the box thinking, and medical providers who truly love their patients and put them first, that has led to our tremendous success and the coming health revolution."
The real question is not whether a clinic can offer hormone therapy, but whether it can explain why a protocol was chosen, why it was adjusted, and why a provider believes the data support that decision. That is where Castle Rock Hormone Health appears to be trying to separate itself from the more transactional end of the category.
© 2026 ScienceTimes.com All rights reserved. Do not reproduce without permission. The window to the world of Science Times.
